Literature DB >> 12965900

Antigen-presenting cell modulation induces a memory response to p24 in peripheral blood leukocytes from human immunodeficiency virus-infected individuals.

Michael A Kolber1, Maria O Saenz.   

Abstract

The accurate determination of human immunodeficiency virus type 1 (HIV-1)-specific proliferative responses is critically important when evaluating immune recovery after highly active antiretroviral therapy. Using a new assay to enhance proliferative responses to recall and HIV antigen, we addressed the questions of whether viral load affects cellular immunity and whether long-term viral load suppression results in loss of antigen-specific responder cells. This assay is based on the fact that lipopolysaccharide (LPS) can augment proliferative responses to antigen after monocyte adherence to a tissue culture plate. Twenty-six HIV-1-infected individuals donated peripheral blood leukocytes (PBL). Proliferation assays against p24, using LPS and cell adherence, were performed on all samples. Medical record abstraction provided information on CD4 cell nadir and time of viral load suppression. PBL from HIV-1-infected individuals with a viral load of <200 copies/ml had a significant proliferative response and a stimulation index of >5 to p24 (12 of 15) compared to those with a viral burden (2 of 11), using the LPS-adherence assay. Proliferative responses to p24 could be found in PBL from virally suppressed donors independent of the CD4 cell nadirs and in the majority of the donors who were virally suppressed for >10 months (7 of 10). The data presented here demonstrate that LPS and monocyte adherence provide a sensitive and specific way to boost proliferative responses to recall and HIV antigens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12965900      PMCID: PMC193886          DOI: 10.1128/cdli.10.5.757-763.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  39 in total

1.  Predictors of HIV-specific lymphocyte proliferative immune responses induced by therapeutic vaccination.

Authors:  R B Moss; M R Wallace; R T Steigbigel; S A Morrison; W K Giermakowska; C J Nardo; J P Diveley; D J Carlo
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.

Authors:  L Al-Harthi; J Siegel; J Spritzler; J Pottage; M Agnoli; A Landay
Journal:  AIDS       Date:  2000-05-05       Impact factor: 4.177

3.  Immune control of HIV-1 after early treatment of acute infection.

Authors:  E S Rosenberg; M Altfeld; S H Poon; M N Phillips; B M Wilkes; R L Eldridge; G K Robbins; R T D'Aquila; P J Goulder; B D Walker
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

4.  CD28 costimulation and T lymphocyte proliferative responses in HIV-1 infection.

Authors:  M Carlesimo; O Pontesilli; A R Varani; M L Bernardi; A M Mazzone; R Rosso; E C Guerra; A Cassone; R Paganelli; F Aiuti
Journal:  Clin Exp Immunol       Date:  1997-09       Impact factor: 4.330

5.  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

Authors:  B Autran; G Carcelain; T S Li; C Blanc; D Mathez; R Tubiana; C Katlama; P Debré; J Leibowitch
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

6.  High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.

Authors:  A C McNeil; W L Shupert; C A Iyasere; C W Hallahan; J A Mican; R T Davey; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

7.  Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count.

Authors:  G P Rizzardi; G Tambussi; P A Bart; A G Chapuis; A Lazzarin; G Pantaleo
Journal:  AIDS       Date:  2000-10-20       Impact factor: 4.177

8.  Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques.

Authors:  Z Hel; D Venzon; M Poudyal; W P Tsai; L Giuliani; R Woodward; C Chougnet; G Shearer; J D Altman; D Watkins; N Bischofberger; A Abimiku; P Markham; J Tartaglia; G Franchini
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

9.  Low concentrations of lipopolysaccharide synergize with peptides to augment human T-cell proliferation and can prevent the induction of non-responsiveness by CTLA4-Ig.

Authors:  M R Goodier; M Londei
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

10.  Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.

Authors:  M Clerici; D R Lucey; J A Berzofsky; L A Pinto; T A Wynn; S P Blatt; M J Dolan; C W Hendrix; S F Wolf; G M Shearer
Journal:  Science       Date:  1993-12-10       Impact factor: 47.728

View more
  2 in total

1.  Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1.

Authors:  Michael A Kolber
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

2.  Memory responses in human immunodeficiency virus type 1-infected individuals with long-term viral load suppression are independent of CD4 cell nadir.

Authors:  Michael A Kolber; Maria O Saenz; Sameer Kaul
Journal:  Clin Diagn Lab Immunol       Date:  2005-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.